The differential expression of PAX2 and PAX8 in the ovarian surface epithelium and fallopian tubal epithelium is an important issue

American Journal of Surgical Pathology

Volumn 36, Issue 7, 2012, Pages 1099-1100

  Tong, Guo Xia ^a   Hamele Bena, Diane ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAIRED BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX2; TUMOR MARKER;

BIOSYNTHESIS; FEMALE; HUMAN; LETTER; METABOLISM; MIXED MULLERIAN TUMOR; NEOPLASM;

FEMALE; HUMANS; MIXED TUMOR, MULLERIAN; NEOPLASMS, GLANDULAR AND EPITHELIAL; PAIRED BOX TRANSCRIPTION FACTORS; PAX2 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84863306591     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182500c1b     Document Type: Letter

References (15)

1. Bowen NJ, Logani S, Dickerson EB, et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007;104:331-337. (Pubitemid 46135661)
2. Chivukula M, Dabbs DJ, O'Connor S, et al. PAX 2: a novel Mullerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma. Int J Gynecol Pathol. 2009;28:570-578.
3. Crum CP, Drapkin R, Kindelberger D, et al. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5:35-44. (Pubitemid 350218778)
4. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol. 1999;72: 437-442. (Pubitemid 29118208)
5. Guioli S, Sekido R, Lovell-Badge R. The origin of the Mullerian duct in chick and mouse. Dev Biol. 2007;302:389-398. (Pubitemid 46216259)
6. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433-443.
7. Laury AR, Hornick JL, Perets R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010;34:627-635.
8. Li J, Abushahin N, Pang S, et al. Tubal origin of 'ovarian' low-grade serous carcinoma. Mod Pathol. 2011;24:1488-1499.
9. Mansouri A, Hallonet M, Gruss P. Pax genes and their roles in cell differentiation and development. Curr Opin Cell Biol. 1996;8:851-857. (Pubitemid 26399946)
10. Masse J, Watrin T, Laurent A, et al. The developing female genital tract: from genetics to epigenetics. Int J Dev Biol. 2009; 53:411-424.
11. Mittag J, Winterhager E, Bauer K, et al. Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology. 2007;148:719-725. (Pubitemid 46143173)
12. Ozcan A, Liles N, Coffey D, et al. PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison. Am J Surg Pathol. 2011;35:1837-1847.
13. Tacha D, Zhou D, Cheng L. Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol. 2011; 19:293-299.
14. Tong GX, Chiriboga L, Hamele-Bena D, et al. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin? Mod Pathol. 2007;20:856-863. (Pubitemid 47077268)
15. Tong GX, Devaraj K, Hamele-Bena D, et al. Pax8: a marker for carcinoma of Mullerian origin in serous effusions. Diagn Cytopathol. 2011;39:567-574.